An internal medicine resident is cross-covering patients on the inpatient psychiatric ward overnight. A 68-year-old woman, who was recently admitted for a severe depressive episode and is maintained on fluoxetine, develops dysuria and suprapubic pain. Urinalysis suggests a urinary tract infection. Without thoroughly reviewing the patient's home medication list or awaiting culture results, the resident prescribes empiric linezolid due to a recent unit outbreak of vancomycin-resistant enterococcus (VRE). The following day, the patient develops altered mental status, autonomic instability, and neuromuscular hyperactivity. A subsequent root cause analysis identifies that the electronic health record (EHR) did not adequately flag the severe drug-drug interaction between the newly prescribed antibiotic and the patient's home antidepressant. Which of the following proposed quality improvement interventions represents the most reliable system-level safeguard to prevent recurrence of this specific error?
- Integrating a computerized provider order entry constraint that blocks the issuance of linezolid for patients with active selective serotonin reuptake inhibitor prescriptions unless a pharmacist provides an override codeAnswer
- BModifying the electronic health record interface to display a brightly colored, flashing banner highlighting all home medications when a provider opens the antibiotic order screen
- CRequiring all cross-covering residents to complete a mandatory training module on the risks of serotonin syndrome and appropriate antibiotic stewardship
- DImplementing a weekly pharmacy audit of all broad-spectrum antibiotic orders placed on the psychiatric unit to ensure targeted, narrow-spectrum therapy is utilized
- ECreating a hospital policy that mandates a formal verbal handoff detailing all high-risk psychotropic medications before the night shift begins